Rheumatoid Arthritis Recruiting Phase 4 Trials for Certolizumab pegol (DB08904)

Also known as: Rheumatoid Arthritis(RA) / Rheumatoid Arthritis, NOS / Rheumatoid Arthritis RA / Rhematoid Arthritis / Rheumatic Arthritis / Rheumatoid Arthritis (RA) / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Arthritis, Rheumatoid (RA) / Rheumatoid Arthritis(RA) / RA / Systemic rheumatoid arthritis / Rheumatoid arthritis (disorder) / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Rheumatoid arthritis NOS / Rheumatoid arthritis NOS (disorder)

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03100253Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGationTreatment
NCT01602302Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid ArthritisTreatment
NCT02466581Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease ActivityTreatment
NCT02242474Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid ArthritisTreatment